Gaps between supply and demand of acute myocardial infarction treatment in Mexico

被引:3
|
作者
Perez-Cuevas, Ricardo [1 ]
Contreras-Sanchez, Saul Eduardo [2 ]
Doubova, Svetlana, V [2 ]
Garcia-Saiso, Sebastian [3 ]
Sarabia-Gonzalez, Odet [4 ]
Pacheco-Estrello, Paulina [5 ]
Arias-Mendoza, Alexandra [6 ]
机构
[1] Interamer Dev Bank, Div Social Protect & Hlth, Jamaica Country Off 6 Montrose Rd, Kingston 6, Jamaica
[2] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Ctr Invest Polit Poblac & Salud, Mexico City, DF, Mexico
[4] Soc Mexicana Calidad Salud, Mexico City, DF, Mexico
[5] Alianza Med Salud AC, Mexico City, DF, Mexico
[6] Inst Nacl Cardiol Ignacio Chavez, Mexico City, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2020年 / 62卷 / 05期
关键词
acute myocardial infarction; hospitalizations; in-hospital mortality; supply capacity; reperfusion; IN-HOSPITAL MORTALITY; AGE; MANAGEMENT; TRENDS; IMPACT; TIME; ELECTROCARDIOGRAM; THERAPY; GENDER; DELAY;
D O I
10.21149/11032
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To analyze acute myocardial infarction (AMI) admissions and in-hospital mortality rates and evaluate the competence of the Ministry of Health (MOH) hospitals to provide AMI treatment. Materials and methods. We used a mixed-methods approach: 1) Joinpoint analysis of hospitalizations and in-hospital mortality trends between 2005 and 2017; 2) a nation-wide cross-sectional MOH hospital survey. Results. AMI hospitalizations are increasing among men and patients aged >60 years;women have higher mortality rates.The survey induded 527 hospitals (2nd level =471;3rd level =56). We identified insufficient competence to diagnose AMI (2nd level 37%, 3rd level 51%), perform pharmacological perfusion (2nd level 8.7%, 3rd level 26.8%), and mechanical reperfusion (2nd level 2.8%, 3rd level 17.9%). Conclusions. There are wide disparities in demand, supply, and health outcomes of AMI in Mexico. It is advisable to build up the competence with gender and age perspectives in order to diagnose and manage AMI and reduce AMI mortality effectively.
引用
收藏
页码:540 / 549
页数:10
相关论文
共 50 条
  • [41] Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
    Tang, Xiaofang
    Liu, Lifu
    Yang, Jingang
    Gao, Zhan
    Zhao, Xueyan
    Qiao, Shubin
    Gao, Runlin
    Wang, Zhifang
    Yuan, Jinqing
    Yang, Yuejin
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [42] Treatment of acute myocardial infarction in women
    Schneider, CA
    Baer, FM
    Erdmann, E
    HERZ KREISLAUF, 1999, 31 (09): : 335 - 339
  • [43] Prognostic Value of Machine Learning in Patients with Acute Myocardial Infarction
    Xiao, Changhu
    Guo, Yuan
    Zhao, Kaixuan
    Liu, Sha
    He, Nongyue
    He, Yi
    Guo, Shuhong
    Chen, Zhu
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (02)
  • [44] Risk factors and clinical characteristics of in-hospital death in acute myocardial infarction with IABP support
    Cao, Jianing
    Liu, Wenxian
    Zhu, Jiajia
    Zhao, Han
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8032 - 8041
  • [45] Ventricular septal defect complicating acute myocardial infarction-still an unsolved problem in the invasive treatment era
    Ledakowicz-Polak, Anna
    Polak, Lukasz
    Zielinska, Marzenna
    CARDIOVASCULAR PATHOLOGY, 2011, 20 (02) : 93 - 98
  • [46] Clinical Differences of Recent Myocardial Infarction Compared With Acute Myocardial Infarction - Insights From the Tokyo CCU Network Multicenter Registry -
    Ito, Ryosuke
    Yamashita, Jun
    Chikamori, Taishiro
    Kondo, Seita
    Mitsuhashi, Yuya
    Iwata, Hiroshi
    Saji, Mike
    Asano, Taku
    Wakabayashi, Kohei
    Yahagi, Kazuyuki
    Shinke, Toshiro
    Mase, Takaaki
    Abe, Kaito
    Miyachi, Hideki
    Higuchi, Satoshi
    Kishi, Mikio
    Tanaka, Hiroyuki
    Yamasaki, Masao
    Miyauchi, Katsumi
    Yamamoto, Takeshi
    Nagao, Ken
    Takayama, Morimasa
    CIRCULATION JOURNAL, 2020, 84 (09) : 1511 - 1518
  • [47] Tenecteplase for treatment of acute myocardial infarction
    Turcasso, NM
    Nappi, JM
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (10) : 1233 - 1240
  • [48] Magnesium in treatment of acute myocardial infarction
    Gowda, RM
    Khan, IA
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 96 (03) : 467 - 469
  • [49] Geographic variation in the treatment of acute myocardial infarction in the VALsartan in acute myocardial iNfarcTion (VALIANT) trial
    Reed, Shelby D.
    McMurray, John J. V.
    Velazquez, Eric J.
    Schulman, Kevin A.
    Califf, Robert M.
    Kober, Lars
    Maggioni, Aldo P.
    Van de Werf, Frans
    White, Harvey D.
    Diaz, Rafael
    Mareev, Viatcheslav
    Murin, Jan
    AMERICAN HEART JOURNAL, 2006, 152 (03) : 500 - 508
  • [50] The use of an intra-aortic balloon pump in patients with cardiogenic shock secondary to acute myocardial infarction
    Qutub, Mohammed A.
    CARDIOTHORACIC SURGEON, 2025, 33 (01)